#Axtria #CEO #Jassi #Chadha #Delivers #Opening #Day #Keynote
Nice, France, Oct. 05, 2022 (GLOBE NEWSWIRE) — Axtria’s President, CEO, and lifelong life sciences tech entrepreneur and data scientist, Jassi Chadha, will deliver the opening day keynote at the Reuters Events Pharma 2022 conference in Nice, France taking place on October 11-13.
Chadha’s presentation, “Patient Engagement – What History Teaches Us About Pharma’s Future Evolution,” will be on Tuesday, October 11, at 9:20 AM CEST. The address will highlight key aspects of pharma’s evolution to date and what future learnings the industry can implement. His talk will include an assessment of the industry’s capabilities, particularly from the lens of how it interacts with patients and the steps it needs to take to reach a new model for patient engagement.
“The global biopharmaceutical sector is at a critical turning point in its history and must look at ways to redefine itself and its relationship fundamentally with its most important customer — the patient,” said Chadha. “I look forward to the opportunity to share my views on this topic with the industry’s leading innovators and company CEOs to initiate a dialogue on suggestions for moving back to what’s important to the patient.”
Chadha is an entrepreneur, a highly regarded data scientist, and an influential thought leader in the rapidly evolving data analytics and artificial intelligence (AI) fields. He currently serves as the President and CEO of Axtria – one of the life sciences industry’s most prominent global players that serve clients in 75+ countries. Previously, he was the co-founder and CEO of marketRx, which Cognizant Technology Solutions acquired. Chadha is an E&Y Entrepreneur of the Year and an advisor, board member, and investor in several companies, including Ocular Therapeutics, SpectraMedix, Estee Advisors, the New Jersey Technology Council, TiE Global, PAN IIT, and is currently a member of the Second District Advisory Council of the Federal Reserve…
Read on GNW: Axtria CEO Jassi Chadha Delivers Opening Day Keynote at































